Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide
0.1.0 - ci-build
Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions
| Active as of 2026-06-04 |
{
"resourceType" : "CodeSystem",
"id" : "cancer-primary-site-cs",
"language" : "en",
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cancer-primary-site-cs</b></p><a name=\"cancer-primary-site-cs\"> </a><a name=\"hccancer-primary-site-cs\"> </a><p>This case-sensitive code system <code>https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">BREAST<a name=\"cancer-primary-site-cs-BREAST\"> </a></td><td>Breast</td><td>C50 — Malignant neoplasm of breast.</td></tr><tr><td style=\"white-space:nowrap\">CERVIX-UTERI<a name=\"cancer-primary-site-cs-CERVIX-UTERI\"> </a></td><td>Cervix Uteri</td><td>C53 — Malignant neoplasm of cervix uteri.</td></tr><tr><td style=\"white-space:nowrap\">CORPUS-UTERI<a name=\"cancer-primary-site-cs-CORPUS-UTERI\"> </a></td><td>Corpus Uteri</td><td>C54 — Malignant neoplasm of corpus uteri.</td></tr><tr><td style=\"white-space:nowrap\">OVARY<a name=\"cancer-primary-site-cs-OVARY\"> </a></td><td>Ovary</td><td>C56 — Malignant neoplasm of ovary.</td></tr><tr><td style=\"white-space:nowrap\">PROSTATE<a name=\"cancer-primary-site-cs-PROSTATE\"> </a></td><td>Prostate</td><td>C61 — Malignant neoplasm of prostate.</td></tr><tr><td style=\"white-space:nowrap\">COLON<a name=\"cancer-primary-site-cs-COLON\"> </a></td><td>Colon</td><td>C18 — Malignant neoplasm of colon.</td></tr><tr><td style=\"white-space:nowrap\">RECTUM<a name=\"cancer-primary-site-cs-RECTUM\"> </a></td><td>Rectum</td><td>C20 — Malignant neoplasm of rectum.</td></tr><tr><td style=\"white-space:nowrap\">OESOPHAGUS<a name=\"cancer-primary-site-cs-OESOPHAGUS\"> </a></td><td>Oesophagus</td><td>C15 — Malignant neoplasm of oesophagus.</td></tr><tr><td style=\"white-space:nowrap\">STOMACH<a name=\"cancer-primary-site-cs-STOMACH\"> </a></td><td>Stomach</td><td>C16 — Malignant neoplasm of stomach.</td></tr><tr><td style=\"white-space:nowrap\">LIVER<a name=\"cancer-primary-site-cs-LIVER\"> </a></td><td>Liver and Intrahepatic Ducts</td><td>C22 — Malignant neoplasm of liver.</td></tr><tr><td style=\"white-space:nowrap\">PANCREAS<a name=\"cancer-primary-site-cs-PANCREAS\"> </a></td><td>Pancreas</td><td>C25 — Malignant neoplasm of pancreas.</td></tr><tr><td style=\"white-space:nowrap\">LUNG<a name=\"cancer-primary-site-cs-LUNG\"> </a></td><td>Lung and Bronchus</td><td>C34 — Malignant neoplasm of bronchus and lung.</td></tr><tr><td style=\"white-space:nowrap\">LARYNX<a name=\"cancer-primary-site-cs-LARYNX\"> </a></td><td>Larynx</td><td>C32 — Malignant neoplasm of larynx.</td></tr><tr><td style=\"white-space:nowrap\">NASOPHARYNX<a name=\"cancer-primary-site-cs-NASOPHARYNX\"> </a></td><td>Nasopharynx</td><td>C11 — Malignant neoplasm of nasopharynx.</td></tr><tr><td style=\"white-space:nowrap\">ORAL-CAVITY<a name=\"cancer-primary-site-cs-ORAL-CAVITY\"> </a></td><td>Oral Cavity and Pharynx</td><td>C00–C14 — Malignant neoplasm of lip, oral cavity and pharynx.</td></tr><tr><td style=\"white-space:nowrap\">THYROID<a name=\"cancer-primary-site-cs-THYROID\"> </a></td><td>Thyroid Gland</td><td>C73 — Malignant neoplasm of thyroid.</td></tr><tr><td style=\"white-space:nowrap\">KIDNEY<a name=\"cancer-primary-site-cs-KIDNEY\"> </a></td><td>Kidney</td><td>C64 — Malignant neoplasm of kidney.</td></tr><tr><td style=\"white-space:nowrap\">BLADDER<a name=\"cancer-primary-site-cs-BLADDER\"> </a></td><td>Urinary Bladder</td><td>C67 — Malignant neoplasm of bladder.</td></tr><tr><td style=\"white-space:nowrap\">SKIN-MELANOMA<a name=\"cancer-primary-site-cs-SKIN-MELANOMA\"> </a></td><td>Skin — Melanoma</td><td>C43 — Malignant melanoma of skin.</td></tr><tr><td style=\"white-space:nowrap\">SKIN-NON-MELANOMA<a name=\"cancer-primary-site-cs-SKIN-NON-MELANOMA\"> </a></td><td>Skin — Non-melanoma</td><td>C44 — Other malignant neoplasms of skin.</td></tr><tr><td style=\"white-space:nowrap\">BRAIN-CNS<a name=\"cancer-primary-site-cs-BRAIN-CNS\"> </a></td><td>Brain and CNS</td><td>C71–C72 — Malignant neoplasm of brain / CNS.</td></tr><tr><td style=\"white-space:nowrap\">BONE<a name=\"cancer-primary-site-cs-BONE\"> </a></td><td>Bone and Articular Cartilage</td><td>C40–C41 — Malignant neoplasm of bone.</td></tr><tr><td style=\"white-space:nowrap\">SOFT-TISSUE<a name=\"cancer-primary-site-cs-SOFT-TISSUE\"> </a></td><td>Soft Tissue / Sarcoma</td><td>C49 — Malignant neoplasm of connective and soft tissue.</td></tr><tr><td style=\"white-space:nowrap\">BURKITT-LYMPHOMA<a name=\"cancer-primary-site-cs-BURKITT-LYMPHOMA\"> </a></td><td>Burkitt Lymphoma</td><td>C83.7 — Burkitt lymphoma.</td></tr><tr><td style=\"white-space:nowrap\">HODGKIN-LYMPHOMA<a name=\"cancer-primary-site-cs-HODGKIN-LYMPHOMA\"> </a></td><td>Hodgkin Lymphoma</td><td>C81 — Hodgkin lymphoma.</td></tr><tr><td style=\"white-space:nowrap\">NON-HODGKIN-LYMPHOMA<a name=\"cancer-primary-site-cs-NON-HODGKIN-LYMPHOMA\"> </a></td><td>Non-Hodgkin Lymphoma</td><td>C82–C86 — Non-Hodgkin lymphoma.</td></tr><tr><td style=\"white-space:nowrap\">LEUKAEMIA-ALL<a name=\"cancer-primary-site-cs-LEUKAEMIA-ALL\"> </a></td><td>Leukaemia — ALL</td><td>C91.0 — Acute lymphoblastic leukaemia.</td></tr><tr><td style=\"white-space:nowrap\">LEUKAEMIA-AML<a name=\"cancer-primary-site-cs-LEUKAEMIA-AML\"> </a></td><td>Leukaemia — AML</td><td>C92.0 — Acute myeloid leukaemia.</td></tr><tr><td style=\"white-space:nowrap\">LEUKAEMIA-CLL<a name=\"cancer-primary-site-cs-LEUKAEMIA-CLL\"> </a></td><td>Leukaemia — CLL</td><td>C91.1 — Chronic lymphocytic leukaemia.</td></tr><tr><td style=\"white-space:nowrap\">LEUKAEMIA-CML<a name=\"cancer-primary-site-cs-LEUKAEMIA-CML\"> </a></td><td>Leukaemia — CML</td><td>C92.1 — Chronic myeloid leukaemia.</td></tr><tr><td style=\"white-space:nowrap\">MULTIPLE-MYELOMA<a name=\"cancer-primary-site-cs-MULTIPLE-MYELOMA\"> </a></td><td>Multiple Myeloma</td><td>C90.0 — Multiple myeloma.</td></tr><tr><td style=\"white-space:nowrap\">KAPOSI-SARCOMA<a name=\"cancer-primary-site-cs-KAPOSI-SARCOMA\"> </a></td><td>Kaposi Sarcoma</td><td>C46 — Kaposi sarcoma.</td></tr><tr><td style=\"white-space:nowrap\">WILMS-TUMOUR<a name=\"cancer-primary-site-cs-WILMS-TUMOUR\"> </a></td><td>Wilms Tumour (Nephroblastoma)</td><td>C64 — Malignant neoplasm of kidney (paediatric).</td></tr><tr><td style=\"white-space:nowrap\">RETINOBLASTOMA<a name=\"cancer-primary-site-cs-RETINOBLASTOMA\"> </a></td><td>Retinoblastoma</td><td>C69.2 — Retinoblastoma.</td></tr><tr><td style=\"white-space:nowrap\">OTHER<a name=\"cancer-primary-site-cs-OTHER\"> </a></td><td>Other / Not Specified</td><td>Primary site not listed or not specified.</td></tr></table></div>"
},
"url" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/cancer-primary-site-cs",
"version" : "0.1.0",
"name" : "CancerPrimarySiteCS",
"title" : "Kenya Cancer Primary Site Code System",
"status" : "active",
"experimental" : false,
"date" : "2026-06-04T14:49:30+00:00",
"publisher" : "Digital Health Agency (DHA), Kenya",
"contact" : [
{
"name" : "Digital Health Agency (DHA), Kenya",
"telecom" : [
{
"system" : "url",
"value" : "https://dha.go.ke"
},
{
"system" : "email",
"value" : "info@dha.go.ke"
}
]
},
{
"name" : "Digital Health Agency Kenya – FHIR Team",
"telecom" : [
{
"system" : "email",
"value" : "info@dha.go.ke",
"use" : "work"
},
{
"system" : "url",
"value" : "https://dha.go.ke",
"use" : "work"
}
]
}
],
"description" : "Codes for the anatomical primary site of a malignancy, aligned with ICD-10 topography.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "KE",
"display" : "Kenya"
}
]
}
],
"caseSensitive" : true,
"content" : "complete",
"count" : 35,
"concept" : [
{
"code" : "BREAST",
"display" : "Breast",
"definition" : "C50 — Malignant neoplasm of breast."
},
{
"code" : "CERVIX-UTERI",
"display" : "Cervix Uteri",
"definition" : "C53 — Malignant neoplasm of cervix uteri."
},
{
"code" : "CORPUS-UTERI",
"display" : "Corpus Uteri",
"definition" : "C54 — Malignant neoplasm of corpus uteri."
},
{
"code" : "OVARY",
"display" : "Ovary",
"definition" : "C56 — Malignant neoplasm of ovary."
},
{
"code" : "PROSTATE",
"display" : "Prostate",
"definition" : "C61 — Malignant neoplasm of prostate."
},
{
"code" : "COLON",
"display" : "Colon",
"definition" : "C18 — Malignant neoplasm of colon."
},
{
"code" : "RECTUM",
"display" : "Rectum",
"definition" : "C20 — Malignant neoplasm of rectum."
},
{
"code" : "OESOPHAGUS",
"display" : "Oesophagus",
"definition" : "C15 — Malignant neoplasm of oesophagus."
},
{
"code" : "STOMACH",
"display" : "Stomach",
"definition" : "C16 — Malignant neoplasm of stomach."
},
{
"code" : "LIVER",
"display" : "Liver and Intrahepatic Ducts",
"definition" : "C22 — Malignant neoplasm of liver."
},
{
"code" : "PANCREAS",
"display" : "Pancreas",
"definition" : "C25 — Malignant neoplasm of pancreas."
},
{
"code" : "LUNG",
"display" : "Lung and Bronchus",
"definition" : "C34 — Malignant neoplasm of bronchus and lung."
},
{
"code" : "LARYNX",
"display" : "Larynx",
"definition" : "C32 — Malignant neoplasm of larynx."
},
{
"code" : "NASOPHARYNX",
"display" : "Nasopharynx",
"definition" : "C11 — Malignant neoplasm of nasopharynx."
},
{
"code" : "ORAL-CAVITY",
"display" : "Oral Cavity and Pharynx",
"definition" : "C00–C14 — Malignant neoplasm of lip, oral cavity and pharynx."
},
{
"code" : "THYROID",
"display" : "Thyroid Gland",
"definition" : "C73 — Malignant neoplasm of thyroid."
},
{
"code" : "KIDNEY",
"display" : "Kidney",
"definition" : "C64 — Malignant neoplasm of kidney."
},
{
"code" : "BLADDER",
"display" : "Urinary Bladder",
"definition" : "C67 — Malignant neoplasm of bladder."
},
{
"code" : "SKIN-MELANOMA",
"display" : "Skin — Melanoma",
"definition" : "C43 — Malignant melanoma of skin."
},
{
"code" : "SKIN-NON-MELANOMA",
"display" : "Skin — Non-melanoma",
"definition" : "C44 — Other malignant neoplasms of skin."
},
{
"code" : "BRAIN-CNS",
"display" : "Brain and CNS",
"definition" : "C71–C72 — Malignant neoplasm of brain / CNS."
},
{
"code" : "BONE",
"display" : "Bone and Articular Cartilage",
"definition" : "C40–C41 — Malignant neoplasm of bone."
},
{
"code" : "SOFT-TISSUE",
"display" : "Soft Tissue / Sarcoma",
"definition" : "C49 — Malignant neoplasm of connective and soft tissue."
},
{
"code" : "BURKITT-LYMPHOMA",
"display" : "Burkitt Lymphoma",
"definition" : "C83.7 — Burkitt lymphoma."
},
{
"code" : "HODGKIN-LYMPHOMA",
"display" : "Hodgkin Lymphoma",
"definition" : "C81 — Hodgkin lymphoma."
},
{
"code" : "NON-HODGKIN-LYMPHOMA",
"display" : "Non-Hodgkin Lymphoma",
"definition" : "C82–C86 — Non-Hodgkin lymphoma."
},
{
"code" : "LEUKAEMIA-ALL",
"display" : "Leukaemia — ALL",
"definition" : "C91.0 — Acute lymphoblastic leukaemia."
},
{
"code" : "LEUKAEMIA-AML",
"display" : "Leukaemia — AML",
"definition" : "C92.0 — Acute myeloid leukaemia."
},
{
"code" : "LEUKAEMIA-CLL",
"display" : "Leukaemia — CLL",
"definition" : "C91.1 — Chronic lymphocytic leukaemia."
},
{
"code" : "LEUKAEMIA-CML",
"display" : "Leukaemia — CML",
"definition" : "C92.1 — Chronic myeloid leukaemia."
},
{
"code" : "MULTIPLE-MYELOMA",
"display" : "Multiple Myeloma",
"definition" : "C90.0 — Multiple myeloma."
},
{
"code" : "KAPOSI-SARCOMA",
"display" : "Kaposi Sarcoma",
"definition" : "C46 — Kaposi sarcoma."
},
{
"code" : "WILMS-TUMOUR",
"display" : "Wilms Tumour (Nephroblastoma)",
"definition" : "C64 — Malignant neoplasm of kidney (paediatric)."
},
{
"code" : "RETINOBLASTOMA",
"display" : "Retinoblastoma",
"definition" : "C69.2 — Retinoblastoma."
},
{
"code" : "OTHER",
"display" : "Other / Not Specified",
"definition" : "Primary site not listed or not specified."
}
]
}